Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

300 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase III study of intensive weekly chemotherapy with recombinant human granulocyte colony-stimulating factor versus standard chemotherapy in extensive-disease small-cell lung cancer. The Japan Clinical Oncology Group.
Furuse K, Fukuoka M, Nishiwaki Y, Kurita Y, Watanabe K, Noda K, Ariyoshi Y, Tamura T, Saijo N. Furuse K, et al. Among authors: ariyoshi y. J Clin Oncol. 1998 Jun;16(6):2126-32. doi: 10.1200/JCO.1998.16.6.2126. J Clin Oncol. 1998. PMID: 9626212 Clinical Trial.
Dose escalation study of carboplatin with fixed-dose etoposide plus granulocyte-colony stimulating factor in patients with small cell lung carcinoma. A study of the Lung Cancer Study Group of West Japan.
Katakami N, Takada M, Negoro S, Ota K, Fujita J, Furuse K, Ariyoshi Y, Ikegami H, Fukuoka M. Katakami N, et al. Among authors: ariyoshi y. Cancer. 1996 Jan 1;77(1):63-70. doi: 10.1002/(SICI)1097-0142(19960101)77:1<63::AID-CNCR12>3.0.CO;2-6. Cancer. 1996. PMID: 8630941 Clinical Trial.
Phase II study of recombinant human interleukin 3 administration following carboplatin and etoposide chemotherapy in small-cell lung cancer patients. SDZ ILE 964 (IL-3) Study.
Kudoh S, Sawa T, Kurihara N, Furuse K, Kurita Y, Fukuoka M, Takada M, Takaku F, Ogawa M, Ariyoshi Y. Kudoh S, et al. Among authors: ariyoshi y. Cancer Chemother Pharmacol. 1996;38 Suppl:S89-95. doi: 10.1007/s002800051046. Cancer Chemother Pharmacol. 1996. PMID: 8765425 Clinical Trial.
300 results